Evidence map›Paper›PMID 39127790›Full record

ArticleScientific data2024

An image-based screen for secreted proteins involved in breast cancer G0 cell cycle arrest.

William A Weston, Jordan A Holt, Anna J Wiecek, James Pilling, Lovisa Holmberg Schiavone, David M Smith, Maria Secrier, Alexis R Barr

Abstract readDataset
In one paragraph

Article in Scientific data, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

William A Weston *MRC Laboratory of Medical Sciences, Imperial College London, Du Cane Road, London, W12 0HS, UK.
Jordan A Holt *MRC Laboratory of Medical Sciences, Imperial College London, Du Cane Road, London, W12 0HS, UK.
Anna J WiecekUCL Genetics Institute, Department of Genetics, Evolution and Environment, University College London, London, UK.
James PillingDiscovery Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, CB2 0AA, UK.ORCID 0000-0003-0801-0951
Lovisa Holmberg SchiavoneDiscovery Biology, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.ORCID 0000-0001-8496-0444
David M SmithEmerging Innovation Unit, Discovery Sciences, R&D, AstraZeneca, Cambridge, CB2 0AA, UK.ORCID 0000-0001-6831-280X
Maria SecrierUCL Genetics Institute, Department of Genetics, Evolution and Environment, University College London, London, UK.
Alexis R BarrMRC Laboratory of Medical Sciences, Imperial College London, Du Cane Road, London, W12 0HS, UK. a.barr@ic.ac.uk.ORCID 0000-0002-6684-8114

Funding

Cancer Research UK (CRUK) C63833/A25729RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/R01356X/1RCUK | Medical Research Council (MRC) MC-A658-5TY60RCUK | Medical Research Council (MRC) MR/N013867/1Wellcome Trust (Wellcome) 204841/Z/16/Z
6 · The paper itself

Abstract

Secreted proteins regulate the balance between cellular proliferation and G0 arrest and therefore play important roles in tumour dormancy. Tumour dormancy presents a significant clinical challenge for breast cancer patients, where non-proliferating, G0-arrested cancer cells remain at metastatic sites, below the level of clinical detection, some of which can re-enter proliferation and drive tumour relapse. Knowing which secreted proteins can regulate entry into and exit from G0 allows us to manipulate their signalling to prevent tumour relapse. To identify novel secreted proteins that can promote breast cancer G0 arrest, we performed a secretome-wide, image-based screen for proteins that increase the fraction of cells in G0 arrest. From a secretome library of 1282 purified proteins, we identified 29 candidates that promote G0 arrest in non-transformed and transformed breast epithelial cells. The assay we have developed can be adapted for use in other perturbation screens in other cell types. All datasets have been made available for re-analysis and our candidate proteins are presented for alternative bioinformatic refinement or further experimental follow up.

Indexed as

Breast NeoplasmsCell Cycle CheckpointsCell Line, TumorFemaleHumansResting Phase, Cell CycleSecretome

Identifiers

PMID39127790
PMCPMC11316812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.